Axsome Therapeutics Inc (AXSM) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Axsome Therapeutics Inc   (NASDAQ: AXSM)
 

Axsome Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Axsome Therapeutics Inc 's inventory turnover ratio sequentially decreased to 1.73 in the second quarter 2026, unsurprisingly, as the Axsome Therapeutics Inc markets continue to deteriorate, and AXSM's faces growing challenges to bring down its inventories. Axsome Therapeutics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 211 days, from 177 days, in the Mar 31 2026 quarter.

Within Healthcare sector 226 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1536, from total ranking in the first quarter 2026 at 1629.

AXSM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Axsome Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AXSM Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 105.43 % 93.12 % 77.59 % 66.66 % 21.16 %
Y / Y Cost of Sales Growth 0.86 % 50.42 % -0.72 % 41.19 % 66.95 %
Inventory Turnover Ratio (TTM) 1.73 2.06 2.2 2.56 2.72
AXSM's Total Ranking # 1536 # 1629 # 1405 # 1344 # 1420
Average inventory processing period 210 177 166 142 134
Seq. Inventory Growth 20.21 % 12.8 % 17.51 % 28.92 % 13 %
Seq. Cost of Sales Growth -7.88 % 19.43 % 3.5 % -11.42 % 37.38 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 63
Healthcare Sector # 227
Overall Market # 1536

Inventory Turnover Ratio Statistics
High Average Low
2.77 2.29 1.73
(Jun 30 2023)   (Jun 30 2026)



AXSM Company Profile >> Back to AXSM Efficiency Comparisons >> Compare AXSM Inventory Turnover Ratio to its Competitors

Financial Statements
Axsome Therapeutics Inc 's Inventories $ 38 Millions Visit AXSM's Balance sheet
Axsome Therapeutics Inc 's Cost of Revenues TTM $ 53 Millions Visit AXSM's Income Statement
What are AXSM's Sales? Visit AXSM's Sales by Segment

Other Inventory Turnover Ratios
Axsome Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AXSM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AXSM's Competitors
Inventory Turnover Ratio for AXSM's Suppliers
Inventory Turnover Ratio for AXSM's Customers

You may also want to know
AXSM's Sales Growth Rates AXSM's Pe Price to earnings ratio AXSM's Receivables Turnover Ratio AXSM's Stock Quote
AXSM's Net Income Growth Rates AXSM's Ps Price to Sales ratio AXSM's Sales per Employee AXSM's Asset Turnover Ratio
AXSM's Net Margin AXSM's Pb Price to Book ratio AXSM's Financial Strength Ratios AXSM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions
IMPACT BIOMEDICAL INC.  2.46 $ 0.414  Millions$ 0  Millions
Quidelortho Corp  2.45 $ 1,481.500  Millions$ 605  Millions
Pro dex Inc   2.43 $ 53.213  Millions$ 22  Millions

Date modified: 2026-08-14T16:48:15+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.